T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for patients with autoimmune diseases. By selectively depleting CD19-positive B-cells, ...

Copyright: © 2025 Elsevier Ltd. Published by Elsevier Ltd. CAR T-cell therapies have revolutionised treatment of many diseases, but their expense means many patients ...

If one insurer views you as risky or just doesn't want to compete for your custom, then even its lowest offers are likely to be pricier than policies from other providers, which could also provide ...

需要更大规模的研究来评估疗效，但早期数据表明，这种方法可以提供一种毒性更低的替代CAR-T细胞疗法，CAR-T细胞疗法已被美国食品和药物管理局批准用于治疗淋巴瘤。 这项研究由圣路易斯华盛顿大学医学院的研究人员共同领导，于1月9日发表在《柳叶刀》杂志 ...

If you don’t care about using your car seat as an infant carrier, you can choose to skip the bucket seat completely. The main trade-off is that you’ll save money on replacing a bucket seat ...

The value of car insurance can shine brightest after an ... However, you could see your rates increase if your driving doesn’t score well. A digital discount is available if you enroll in ...

2025年1月13日，科济药业宣布，公司自主研发的一款靶向CD19/CD20的通用型CAR-T细胞治疗候选产品KJ-C2219（研发药代号）已完成研究者发起的临床试验（IIT）的首例受试者给药。   KJ-C2219是基于科济药业自主研发的THANK-u Plus平台开发，计划用于治疗血液恶性肿瘤和自身免疫性疾病，目前正在中国开展针对复发/难治性B细胞非霍奇金淋巴瘤（R/R B-NHL）研究者发起 ...

This review systematically summarizes the research progress of mesenchymal stem cell (MSC) and chimeric antigen receptor T cell (CAR-T) therapies in scleroderma and discusses the challenges and future ...

T-Mobile is one of the fastest-growing carriers in the United States thanks to aggressive pricing, marketing, and a penchant for doing the unexpected. The Uncarrier has significantly shaken up the ...

The best T-Mobile cell phone plans give you access to unlimited data each month. But the question you need to answer when you have to pick a T-Mobile plan is which of T-Mobile's several unlimited ...